FDA meeting time change
This article was originally published in The Tan Sheet
Executive SummaryFDA's public meeting, "Preparation for International Conference Harmonization meetings in Brussels, Belgium," is rescheduled from April 6 to May 3 and will start at 11:30 a.m., the agency says April 4. FDA will solicit public input at the meeting prior to the next steering committee and expert working group meetings in Brussels...
You may also be interested in...
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.
While contract manufacturer ABH Nature' complied with consent decree, Sen. Chuck Schumer says FDA is late in enforcing against noncompliant firms across the supplement sector. Other recent consumer health recalls include more OTC ranitidine tablets due to the potential carcinogen NDMA found in the heartburn ingredient and four versions of Sure 48HR Anti-Perspirant & Deodorant with labeling errors.